Honma, N., Inoue, T., Tsuchiya, N., Koizumi, A., Yamamoto, R., Nara, T., . . . Habuchi, T. (2020). Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib. Health Sci Rep.
Styl ChicagoHonma, Naoko, et al. "Prognostic Value of Plasminogen Activator Inhibitor‐1 in Biomarker Exploration Using Multiplex Immunoassay in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib." Health Sci Rep 2020.
Citace podle MLAHonma, Naoko, et al. "Prognostic Value of Plasminogen Activator Inhibitor‐1 in Biomarker Exploration Using Multiplex Immunoassay in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib." Health Sci Rep 2020.